These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32697358)

  • 1. The Hippo in the room: Targeting the Hippo signalling pathway for osteosarcoma therapies.
    Rothzerg E; Ingley E; Mullin B; Xue W; Wood D; Xu J
    J Cell Physiol; 2021 Mar; 236(3):1606-1615. PubMed ID: 32697358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo signaling pathway in liver regeneration and tumorigenesis.
    Hong L; Cai Y; Jiang M; Zhou D; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
    Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
    J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo pathway - brief overview of its relevance in cancer.
    Zygulska AL; Krzemieniecki K; Pierzchalski P
    J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.
    Johnson R; Halder G
    Nat Rev Drug Discov; 2014 Jan; 13(1):63-79. PubMed ID: 24336504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo Signaling Pathway in Gliomas.
    Masliantsev K; Karayan-Tapon L; Guichet PO
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
    Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
    BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression.
    Fu CY; Chen MC; Tseng YS; Chen MC; Zhou Z; Yang JJ; Lin YM; Viswanadha VP; Wang G; Huang CY
    Environ Toxicol; 2019 Aug; 34(8):902-911. PubMed ID: 31044527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippo and TGF-β interplay in the lung field.
    Saito A; Nagase T
    Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L756-67. PubMed ID: 26320155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
    Chai J; Xu S; Guo F
    Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian Hippo signalling: a kinase network regulated by protein-protein interactions.
    Hergovich A
    Biochem Soc Trans; 2012 Feb; 40(1):124-8. PubMed ID: 22260677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Roles of NDR Protein Kinases in Hippo Signalling.
    Hergovich A
    Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
    Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
    Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
    Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the Hippo signalling pathway during bovine preimplantation embryo development.
    Sharma J; Madan P
    Reprod Fertil Dev; 2020 Feb; 32(4):392-401. PubMed ID: 31718770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.